Druggio Logo

Druggio

Ilumya

Made by

Active Ingredient

Tildrakizumab (genetical recombination)

Prospectus

Link

Approval date

2020/6/29

Treats

Dosages

  • ILUMYA Subcutaneous Injection 100mg Syringe - 487413円/筒